| Investment Opportunities in Women's Health Tro Kalayjian submits:The next several months will be an exciting time for the women’s health space, with several important events that may represent an opportunity for investors. Most notably, Pfizer (PFE) has completed data collection for it's 2186-patient study of Pristiq for the treatment of vasomotor symptoms, more commonly known as hot flashes. Wyeth, now part of Pfizer, began Pristiq's large trial in July of 2007, when the FDA asked Wyeth to produce a more comprehensive safety profile for Pristiq. At the time, Wyeth’s CEO, Robert Essner, said:Sales for Pristiq may top $2 billion, if Pristiq is approved for the "hot flash" indication.Complete Story » seekingalpha.com |
Humana's Net Jumps 21% Humana said profit jumped 21% on improved revenue as membership increased. The managed-care provider raised its 2010 earnings target again. online.wsj.com |
Roche to Buy BioImagene, U.S. Diagnostics Firm Roche said it will buy closely held BioImagene for $100 million, helping the Swiss drug company to extend its diagnostics business. online.wsj.com |
Why Pharmathene Could Go From $2 to $20 James Altucher submits:In the biotech sector I try to find stocks that have minimal downside but potential for 10x returns. Back in July, 2007, for instance, I took a lot of heat writing bullishly about DNDN on TheStreet.com. More recently, I wrote this article for the Wall St Journal on June 30 about Pharmathene (PIP) when it was at 1.56. I listed three catalysts then and suggested that the stock should minimally be catapulted in the $7-10 range. I wanted to give an update on what's gone on since then and why I think the stock could eventually be even double what I initially thought. First off, the stock is now at $2 after a competitive company, SIGA, three days ago received a contract from the government that could be worth conceivably up to $2.8bb for its smallpox antiviral product.Complete Story » seekingalpha.com |
Sharps Compliance: PELLA-DRX™ - Video Sharps Compliance Inc. Repurposes Medical Waste into New Products feedproxy.google.com |